NEURIZON THERAPEUTICS LIMITED

Press Releases Neurizon Therapeutics Limited

Equities

NUZ

AU0000357261

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 11:15:30 11/07/2025 am IST			5-day change	1st Jan Change
0.1650 ^AUD	+3.12%		+3.12%	-2.94%

10/07	Neurizon Therapeutics Receives US FDA Support to Lift Clinical Hold on ALS Trial	MT
03/07	Elanco Animal Health Enters Into Licensing Agreement With Neurizon for Monepantel	MT

Press Releases

PharmAust advances monepantel for motor neurone disease towards FDA approval	28/24/28	AQ
PharmAust : Appendix 4C and Quarterly Update	20/22/20	PU
PharmAust : Application for quotation of securities - PAA	16/21/16	PU
Application for quotation of securities - PAA	09/21/09	PU
PharmAust Limited Clinical Trial in Dogs for Treatment of Canine Cancers	02/15/02	AW

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!